captopril has been researched along with natriuretic peptide, brain in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coutie, WJ; Lang, CC; Motwani, JG; Rahman, AR; Struthers, AD | 1 |
| Cheung, B | 1 |
| Jougasaki, M; Kato, H; Kikuta, K; Nakao, K; Sumida, H; Tanaka, H; Yasue, H; Yoshimura, M | 1 |
| Kennedy, N; McAlpine, H; Motwani, JG; Struthers, AD | 1 |
| Bäcklund, T; Eriksson, A; Grönholm, T; Laine, M; Palojoki, E; Tikkanen, I; Vuolteenaho, O | 1 |
| Orda, A; Przewłocka-Kosmala, M; Salomon, P | 1 |
| Falcão, LM; Pinto, F; Ravara, L; van Zwieten, PA | 1 |
| Gottsäter, A; Ohlin, AK; Ohlin, H; Tingberg, E | 1 |
| Dai, M; He, JR; Wen, QX | 1 |
| Howlett, JG; Lamond, NW | 1 |
| Anand, I; Dickstein, K; Manhenke, C; Ng, L; Orn, S; Squire, IB | 1 |
| Bouhuizen, AM; Danser, AH; Garrelds, IM; Leijten, F; Moltzer, E; van Esch, JH; van Veghel, R | 1 |
| Hsieh, YM; Huang, CY; Kuo, WW; Lin, CC; Lin, PP; Tsai, CC; Tsai, CH; Tsai, FJ | 1 |
| Dickinson, BA; Hullinger, TG; Latimer, PA; Lewton, SM; Lynch, JM; Montgomery, RL; Semus, HM; Seto, AG; Stack, C; van Rooij, E | 1 |
| Awwad, ZM; El-Ganainy, SO; El-Khatib, AS; ElMallah, AI; Khattab, MM | 1 |
1 review(s) available for captopril and natriuretic peptide, brain
| Article | Year |
|---|---|
Should we inhibit angiotensin-converting enzymes in acute heart failure?
Topics: Acute Disease; Administration, Sublingual; Algorithms; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Practice Guidelines as Topic; Pulmonary Edema; Treatment Outcome; Vasodilator Agents | 2007 |
7 trial(s) available for captopril and natriuretic peptide, brain
| Article | Year |
|---|---|
Effect of angiotensin-converting enzyme inhibition on plasma brain natriuretic peptide levels in patients with heart failure.
Topics: Aged; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Captopril; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Radioimmunoassay; Single-Blind Method | 1992 |
Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Captopril; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Pulmonary Wedge Pressure; Time Factors; Vascular Resistance | 1994 |
Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.
Topics: Adult; Aged; Atrial Natriuretic Factor; Captopril; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Prospective Studies; Sensitivity and Specificity; Stroke Volume; Ventricular Function, Left | 1993 |
BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Biphenyl Compounds; Captopril; Cardiac Output, Low; Chronic Disease; Echocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Irbesartan; Male; Middle Aged; Natriuretic Peptide, Brain; Predictive Value of Tests; Radiography, Thoracic; Radionuclide Ventriculography; Tetrazoles; Ventricular Dysfunction, Left | 2004 |
Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Comorbidity; Delayed-Action Preparations; Dinoprost; Female; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxidative Stress; Ramipril; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left | 2006 |
[Effects of xinshuai mistura on plasma angiotensin II, atrial natriuretic peptide and N terminal pro-brain natriuretic peptide in patients with heart failure].
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Phytotherapy; Single-Blind Method; Treatment Outcome | 2006 |
Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Heart Ventricles; Humans; Losartan; Magnetic Resonance Imaging; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Severity of Illness Index; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Remodeling | 2007 |
7 other study(ies) available for captopril and natriuretic peptide, brain
| Article | Year |
|---|---|
Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Heart Failure; Humans; Natriuretic Peptide, Brain; Nerve Tissue Proteins | 1995 |
Dual inhibition of angiotensin converting enzyme and neutral endopeptidase by omapatrilat in rat in vivo.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Heart; Kidney; Male; Myocardium; Natriuretic Agents; Natriuretic Peptide, Brain; Neprilysin; Organ Size; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Wistar; Thiazepines | 2001 |
[Plasma levels of brain natriuretic peptide, cyclic 3'5'-guanosine monophosphate, endothelin 1, and noradrenaline in patients with chronic congestive heart failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Case-Control Studies; Cyclic GMP; Diuretics; Dose-Response Relationship, Drug; Endothelin-1; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Radioimmunoassay; Time Factors | 2003 |
Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Biphenyl Compounds; Blood Pressure; Captopril; Disease Models, Animal; Dose-Response Relationship, Drug; Fumarates; Heart; Heart Ventricles; Hypertension; Hypertrophy; Irbesartan; Male; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Tetrazoles | 2010 |
Inhibition of cardiac hypertrophy by probiotic-fermented purple sweet potato yogurt in spontaneously hypertensive rat hearts.
Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Calcineurin; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Captopril; gamma-Aminobutyric Acid; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor II; Interleukin-6; Ipomoea batatas; Male; Mitogen-Activated Protein Kinase 7; Natriuretic Peptide, Brain; NFATC Transcription Factors; Organ Size; Protein Kinase C-alpha; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Yogurt | 2012 |
Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Captopril; Disease Models, Animal; Disease Progression; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Heart Failure; Hypertension; Male; MicroRNAs; Natriuretic Peptide, Brain; Oligonucleotide Array Sequence Analysis; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Sodium Chloride; Treatment Outcome | 2013 |
Telmisartan and captopril ameliorate pregabalin-induced heart failure in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cyclic AMP-Dependent Protein Kinases; Drug Therapy, Combination; Echocardiography; Heart Failure; Male; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Pregabalin; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Telmisartan | 2019 |